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The metabolic syndrome (MS) has been associated with poor performances in
multiple cognitive domains, as processing speed, visuo-spatial abilities, and executive
functioning. Exercise is a critical factor for MS people’s vulnerability to cognitive
dysfunction, because this may be beneficial to reduce cognitive impairment, but limited
physical activity and impaired cerebral blood flow in response to exercise have been
reported by individuals suffering from MS. Using an attentional interference test, the
Bivalent Shape Task (BST), and metaboreflex, we analyzed cognitive performance and
cerebral oxygenation (COX) in 13 MS people (five women), and 14 normal age-matched
control (CTL, six women). Five different sessions were administered to all participants,
each lasting 12 min: control exercise recovery (CER), post-exercise muscle ischemia
(PEMI) to activate the metaboreflex, CER + BST, PEMI + BST, and BST alone. During
each session, cognitive performance was assessed by means of response times and
response accuracy with which participants make the decision and COX was evaluated
by near infrared spectroscopy with sensors applied in the forehead. Compared to CTL,
MS group performed significantly worse in all sessions (F = 4.18; p = 0.05; ES = 0.13):
their poorest performance was observed in the BST alone session. Moreover, when
BST was added to PEMI, individuals of the CTL group significantly increased their COX
compared to baseline (103.46 ± 3.14%), whereas this capacity was impaired in MS
people (102.37 ± 2.46%). It was concluded that: (1) MS affects cognitive performance;
(2) people with MS were able to enhance COX during exercise, but they impair their
COX when an attentional interference task was added.
Keywords: metabolic syndrome, exercise, cognitive processes, NIRS, attentional task
INTRODUCTION
The metabolic syndrome (MS) is a cluster of interrelated conditions, increasing the risk of heart
disease, heart disease, Type 2 diabetes mellitus, and stroke, among other health problems. The
International Diabetes Federation estimated that 20–25% of the global adult population su ers
from MS (International Diabetes Federation, 2015), which increases in older adults, but rates of
MS ranging between 0 and 19.2% were also reported among children and adolescents (Friend et al.,
2013). According to clinical guidelines, an individual su ers from MS if three or more risk factors
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as high blood glucose, high blood pressure, high plasma
triglycerides, high waist circumference, and low HDL cholesterol
are present (Expert Panel on Detection, Evaluation, and
Treatment of High Blood Cholesterol in Adults, 2001;
Alberti et al., 2009).
The MS has been correlated to cognitive dysfunction and poor
performances in multiple domains as processing speed, memory,
semantic fluency, visuo-spatial abilities, sustained attention,
and executive function (Ya e et al., 2004; Segura et al., 2009;
van den Berg et al., 2009; Solfrizzi et al., 2011; Yates et al.,
2012; Wooten et al., 2019). In order to explain the e ects of
MS on cognitive impairments di erent risk factors such as
neuroinflammation, oxidative stress, impaired vascular reactivity,
and abnormal brain lipid metabolism have been taken into
account (Yates et al., 2012).
Although every single risk factor plays some role in the decline
of cognitive function, the question was raised as to whether
these risk factors taken together have a higher predictive value
for cognitive deterioration. Cohort studies with cross-sectional
research designs (Ya e et al., 2004; Segura et al., 2009; Vieira
et al., 2011) or longitudinal (Ya e et al., 2009; Akbaraly et al.,
2010) build a strong case for MS being associated with poor
cognitive performance than its individual components. MS is
mostly associated with impaired executive functioning, among
all reported deficits (Wooten et al., 2019), although findings are
mixed, with some cross-sectional studies reporting no e ects
(Tournoy et al., 2010; Kim et al., 2011) or even better cognitive
performance among older women su ering from MS (Laudisio
et al., 2008). Clearly, some of the ambiguity in the results obtained
could be the e ect of methodological issues as cognitive domains
selected, demographic characteristics (i.e., di erences in age, race,
gender, educational level, and socioeconomic position),MS status
vs. persistent MS, health status of experimental and control
group, and complexity in splitting the impact of individual factors
from that of the MS itself (Akbaraly et al., 2010); further studies
incorporating some protective factors have been also claimed
(Yates et al., 2012).
The vascular risk factors as, for example, high blood sugar
and low level of HDL cholesterol, are all potentially reversible
and current recommendations for the treatment ofMS encourage
intensive therapeutic lifestyle changes such as increasing regular
physical activity and reducing the dietary intake of saturated fat
and cholesterol. Regular physical activity of moderate intensity
can reduce singular metabolic risk factors while benefits of
exercise on multiple risk factors were also reported (Laaksonen
et al., 2002; Katzmarzyk et al., 2003; Holme et al., 2007). Previous
researches show evidence that a lower prevalence of MS is
associated with at least 150 min weekly of moderate-intensity PA
(Strasser, 2013). However, to appreciate the benefits of movement
it is relevant to distinguish among physical activity and exercise:
while physical activity refers to any movement produced by
skeletal muscles that require energy, exercise enhances the
capacity and e ciency of the cardiorespiratory system and
muscular strength associated with health and functional capacity
(Caspersen et al., 1985). Improvements in fitness are noticeable in
enhancement in executive-control processes such as, inhibition,
planning, scheduling, coordination, and working memory.
Due to brain activation and to the increase of cerebral blood
flow (CBF) exercise may be therefore beneficial to reduce
cognitive impairment (Secher et al., 2008; Kim et al., 2011).
Interventions, such as exercise training programs, increase the
cognitive performance of one-half standard deviation on average,
regardless of the type of training method, cognitive task, or
participants’ characteristics (Colcombe and Kramer, 2003). Other
potential mechanisms that account for the cognition-enhancing
e ects of exercise encompassed vascularization, neuroendocrine
response to stress, neuroinflammation, brain amyloid burden,
or other favorable e ects on neuronal survivability and function
(Baker et al., 2010).
Moreover, muscle metaboreflex activated by metabolites
accumulating in the muscle during contraction can enhance
the sympathetic tone and consequently the sympathetic nervous
system (SNS) activity (Boushel, 2010). However, in people
with metabolic disorders impaired CBF was reported whether
caused by exercise (Kim et al., 2015; Vianna et al., 2015) or
by stimulation of metaboreflex (Delaney et al., 2010; Milia
et al., 2015; Crisafulli, 2017). Consequently, we have assumed
that exercise is a critical factor for MS people’s vulnerability to
cognitive dysfunction, because may support cognitive functions,
but limited physical activity and impaired CBF after exercise
has been reported by individuals su ering from MS. When
cerebral oxygenation (COX) is reduced after exercise (or
stimulation of metaboreflex) cognitive functions can deteriorate
and people experience early fatigue (González-Alonso et al., 2004;
Rasmussen et al., 2010). Subclinical alterations in cerebrovascular
reactivity and cerebral metabolism may denote early brain
compromise associated with peripheral metabolic disturbances
(Yates et al., 2012). Individuals with MS may not be able to
retain an optimal neuronal environment, mostly when a high
demanding cognitive task is superimposed to exercise. We
hypothesized therefore that the association betweenmetaboreflex
and a contemporary mental task could result in an impairment
of cognitive performance and in a reduced COX, in people
su ering fromMS.
MATERIALS AND METHODS
Participants
Two groups of participants were enrolled:
• MS group: 13 patients [five women, mean ± standard
deviation (SD) of the mean of age 52.9 ± 11.2 years], who
received a diagnosis of MS from at least a year (range
1–6 years). To be included in the study individual have
to present three or more of the following five metabolic
factors: (1) waist circumference >102 and >88 cm for
men and women, respectively; (2) high blood pressure
( 130/85 mmHg); (3) low HDL cholesterol (40 and
50 mg/dL in men and women, respectively); (4) high
triglycerides ( 150 mg/dL); and (5) high fasting glucose
level ( 100 mg/dL).
• Control (CTL) group: 14 age-matched healthy participants
(six women, mean± SD of age 50.8± 8.1 years), una ected
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by any metabolic disease as resulted from anamnesis and
physical examination.
In addition to age 18 and  65 years, exclusion criteria
encompassed significant medical disease that could interfere
with the autonomic function. Smokers and individuals taking
sympatho-mimetics, b-blockers, and/or tricyclic antidepressants
were also excluded.
Procedure
After enrolment, participants attended the laboratory on
two occasions: one preliminary baseline visit and one
experimental phase.
Baseline visit: All participants received a medical examination
with anamnesis, anthropometric measures (weight, height, body
mass index, waist circumference, and body composition), ECG,
and blood pressure. To assess physical capacity all participants
performed a cardiopulmonary exercise test (CPT) on a cycle
ergometer (CUSTO Med, Ottobrunn, Germany): maximum
heart rate (HRmax), maximal oxygen uptake (VO2max),
and maximum workload (Wmax) were recorded. During the
baseline visit, the participants familiarized with the laboratory
equipment and sta .
Experimental phase: this phase started after at least 3 days
(range 3–7 days) from baseline visit and included in random
order five sessions (Figure 1). All participants were randomly
assigned to the following five sessions. All sessions were
composed of four blocks each lasting 3 min, for a total of 12 min.
Sessions were spaced by at least 15 min of recovery. Recovery
was considered complete when the heart rate was not higher
than 5 bpm compared with the pre-exercise level. Participants
were requested to abstain from alcohol, ca einated beverages,
and heavy exercise for 12 h prior to coming to the laboratory.
This study was carried out in accordance with the
recommendations of the Code of Ethics for Research in
Psychology, Italian Association of Psychology. The protocol was
approved by the ethics committee of the University of Cagliari.
All participants gave written informed consent in accordance
with the Declaration of Helsinki.
The experimental phase started after at least 3 days (range
3–7 days) from baseline visit and included in random order the
following five sessions (Figure 1):
Specifically, sessions were as follows:
• Post-exercise muscle ischemia (PEMI): 3 min of resting,
followed by 3 min of exercise, consisting of rhythmic (30
compressions/min). The handgrip was settled at 30% of
the maximum previously assessed as the peak reached
during five maximal compressions executed on a hydraulic
dynamometer (MAP 1.1, Kern, Balingen, Germany). The
exercise was followed by 3 min of PEMI on the exercised
arm induced by rapidly inflating an upper arm biceps
tourniquet to 50 mmHg above peak exercise systolic
pressure. The cu  was kept inflated for 3 min. Three
minutes of recovery was further allowed after the cu  was
deflated, for a total of 6 min of recovery.
• Control exercise recovery (CER): the same rest-exercise
protocol used for PEMI was performed followed by a CER
of 6 min without tourniquet inflation. The CER session
was employed to have a control recovery situation without
metaboreflex activation.
• Mental task (MT): A computerized attentional interference
test, the Bivalent Shape Task (BST) (Esposito et al., 2013),
was used to test the ability to suppress interference. The
BST asks the participant to decide whether a shape at the
center of the screen is a square or a circle. The stimulus
FIGURE 1 | Schematic representation of the various sessions of the study protocol. PEMI, post-exercise muscle ischemia; CER, control exercise recovery; MT,
mental task; CER + MT, control exercise recovery + mental task; PEMI + MT, post-exercise muscle ischemia + mental task.
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FIGURE 2 | Cerebral oxygenation data during control exercise recovery
(CER), post-exercise muscle ischemia (PEMI), mental task (MT), control
exercise recovery + mental task (CER + MT), and post-exercise muscle
ischemia + mental task (PEMI + MT) tests in the metabolic syndrome (MS,
n = 13) and the control (CTL, n = 14) groups. The dotted line indicates rest
level. Values are mean ± SD. A horizontal bracket indicates the overall main
effect of groups; a vertical bracket indicates the overall main effect of
condition. ⇤p < 0.05 vs. CER test of the same group.
shape is presented either in blue, red, or an unfilled
black outline. Visual response cues are provided below
the stimulus, indicating the side of the response and
are shaded in either red or blue. Three trial types were
presented: neutral trials in which the stimulus is black and
white; congruent trials, in which the (irrelevant) color of
the stimulus matches the response cue; and incongruent,
in which the (irrelevant) color mismatches the response
cue. Compared to the condition in which the dominant
response and the activated response are the same (e.g.,
congruent trials), a response interference is stimulated
whenever the dominant response has to be suppressed in
order to give the instructed response, as in the incongruent
trials: this results in a deterioration of the performances.
Dependentmeasures are the speed and accuracy with which
participants take the decision: the speed was assessed in
ms, the accuracy as percent of correct responses. The
MT started after 6 min of rest and lasted for 3 min.
Three further minutes of recovery was allowed after the
termination of MT.
• CER + MT: the same rest-exercise protocol used for CER
was performed. The exercise phase was followed by a MT
session of 3 min, i.e., the same duration of the MT session
described previously. Three furtherminutes of recovery was
allowed after the termination of MT.
• PEMI + MT: the same rest-exercise protocol used for
PEMI was performed. The exercise phase was followed
by 3 min of contemporary PEMI and MT. Three further
minutes of recovery was allowed after the termination of
the PEMI+MT period.
Throughout sessions, COX was assessed by means of near
infrared spectroscopy (NIRS; Nonin, SenSmart X-100, Plymouth,
MN, United States), which provided a measure of oxygenated
Hb in the brain tissue. It is recognized that changes in COX are
representative of cortical activation (Strangman et al., 2002) and
COX assessments by means of NIRS during mental tasks such as
calculation, interference, or Stroop tasks were already reported
(Plichta et al., 2006; Verner et al., 2013; Ferreri et al., 2014).
Two NIRS sensors were placed on the right and left subject’s
forehead above the eyebrow, in the regions between Fp1 and
F3 (international EEG 10–20 system) and adjusted according
to the strong signal. Oxygenated Hb measured by NIRS can be
considered an index of regional tissue blood flow as previously
reported (Suzuki et al., 2004). Since the absolute concentration
of oxygenated Hb could not be acquired, because the path
length of NIRS light within the brain tissue was unknown,
relative changes of NIRS signals against the baseline values were
taken into account.
This study was carried out in accordance with the
recommendations of the Code of Ethics for Research in
Psychology, Italian Association of Psychology. The protocol was
approved by the ethics committee of the University of Cagliari.
All participants gave written informed consent in accordance
with the Declaration of Helsinki.
Data Analysis
Preliminary analysis showed that all the BST protocols were valid
with an accuracy of responses equal or above the predetermined
threshold. A preliminary check of data, executed by means of the
Kolmogorov–Smirnov test with Lilliefors correction that renders
this test less conservative, has confirmed a normal distribution for
all parameters examined. The t-test for independent groups was
used to assess di erences in anthropometric characteristics, levels
of triglycerides, HDL cholesterol, fasting glucose, and results of
the CPT. Two-way ANOVA (factors: group and condition) was
executed to assess (a) response times (ms) on BST; (b) change in
COX reported as % changes from rest. Statistics were carried out
utilizing commercially available software (GraphPad Prism and
SPSS ver. 17.0). Statistical significance was established as a p-value
of<0.05 in all cases.
RESULTS
The protocol was completed by all participants none reported
discomfort or unbearable pain during PEMI. Anthropometric
characteristics of both groups together with results of the baseline
visit are shown in Table 1.
Participants of the MS group had a higher weight, BMI, waist
circumference, FM, SBP, DBP, and fasting glucose with respect to
the CTL group. Table 1 also shows that FFM, TBW, VO2max,
Wmax, and HRmax were lower in the MS than in the CTL group.
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TABLE 1 | Anthropometric characteristics of both groups together with results of
the screening medical examination and of cardiopulmonary test.
Anthropometric characteristics CTL MS P-value
Height (cm) 169.5 ± 10.29 165.92 ± 8.08 0.326
Body mass (kg) 69.45 ± 12.23 96.73 ± 14.13 < 0.001
Body mass index (kg/m2) 24.03 ± 2.74 35.26 ± 5.65 < 0.001
Waist circumference (cm) 80.75 ± 9.85 113.58 ± 7.24 < 0.001
Fat mass (%) 21.8 ± 5.5 35.9 ± 7.3 < 0.001
Fat-free mass (%) 78.2 ± 5.5 64.1 ± 7.3 < 0.001
Total body water (%) 57.1 ± 4.5 47.3 ± 5.5 < 0.001
Systolic blood pressure (mmHg) 111.07 ± 9.84 123.85 ± 8.69 0.001
Diastolic blood pressure (mmHg) 73.57 ± 6.91 81.15 ± 6.50 0.007
Maximal O2 uptake (mL/kg/min) 31.70 ± 9.36 19.99 ± 3.46 < 0.001
Maximum workload (W) 199.30 ± 84.39 140.76 ± 29.56 0.026
Maximum heart rate (bpm) 158.80 ± 12.45 147.84 ± 13.15 0.035
Values are mean ± SD. CTL = controls (n = 14), MS = Metabolic Syndrome
patients (n = 13).
Table 2 shows that the significant di erences between groups
were found only in BST scores, while COX was significantly
a ected by the condition. In particular, MS group, compared to
CTL group, performed significantly worse in all sessions wereMT
was included (F = 4.18; p = 0.05; ES = 0.13). In both groups, COX
increased during the CER, the PEMI, the CER + MT, and the
PEMI+MT tests compared to the MT test.
Moreover, when MT was added to PEMI, individuals of
the CTL group significantly increased their COX compared to
baseline (103.46 ± 3.14%), whereas this capacity was impaired
in MS people (102.37± 2.46%, see Figure 2).
DISCUSSION
The management of chronic diseases requires to assume and
maintain an active role centered on: (a) acquisition of self-
regulated behavior; (b) suppression of interferent habitual
response (such as sitting after meals); and (c) replacement
of habit with other healthier behavior (such as going for
a walk) (Settineri et al., 2019). Exercise appears to be a
useful strategy to treat MS, because it could reduce cognitive
impairment and risk to develop Type 2 diabetes mellitus,
stroke, and heart diseases. However, adults with MS may
be at increased risk of non-adherence exercise due to a
concurring rise in behavioral requests (e.g., nutrition planning,
glucose tracking, medication timing) and decrease in cognitive
function (Olson et al., 2017). Compared to modifications of
nutrition or taking medications, exercise requires more time to
be practice and deliberate continuous e ort of planning and
monitoring: people su ering from chronic diseases often perceive
its adoption as a significant and di cult change in their lifestyle
(Guicciardi et al., 2014).
The principal aim of the present investigation was to
characterize the mental performance and the COX in
people su ering from MS during exercise, associating a
mental task (BST) to metaboreflex activated by means of
the PEMI method.
About the mental performance, significant di erences in
response times were found between groups: the participants
su ering from the MS took longer to discriminate the shapes
of BST. Compared to CTL group, their performances were
always worse, supporting the hypothesis that MS can impair
executive functions, such as interference suppression. The
di erence in cognitive performance due to MS was small
(ES = 0.13); however, considering the high prevalence of
MS, the burden of impaired cognition due to the MS may
be substantial in the overall population (Vieira et al., 2011).
The individuals su ering from MS may not be able to
maintain an optimal performance during high demanding
tasks as BST, which requires participants to control the
interference due to the stimulus characteristic (e.g., color)
and focus on the relevant information (e.g., shape) to
give the correct response. Both groups have reported their
poorest cognitive performance in the MT alone trial, but
when PEMI or CER was superimposed their response times
improved even if not significantly. As know, exercise has
more e ect on executive functions, than on any other type of
cognitive process (Colcombe and Kramer, 2003); however, to
evaluate concurrent improvements in other cognitive processes,
such as working memory, sustained attention, or visuo-
spatial abilities further researches should be conducted using
more suitable tasks.
About the COX, participants su ering from MS, compared
with healthy controls, were unable to increase COX when
BST was superimposed to the PEMI-induced metaboreflex
activation. This occurrence suggests that people su ering from
MS were not able to increase COX to the same extent of
CTL groups when a mental task was superimposed to the
PEMI-induced metaboreflex activation. In both groups during
the mental task, COX tended to slightly increase with respect
TABLE 2 | Bivalent shape test (BST) scores and cerebral oxygenation (COX) during the mental task (MT), control exercise recovery + mental task (CER + MT), and
post-exercise muscle ischemia + mental task (PEMI + MT) tests for control (CTL, n = 14) and metabolic syndrome (MS, n = 13) groups.
Anthropometric characteristics MT CER + MT PEMI + MT P-value condition
effect
P-value group
effect
P-value
interaction
BST (ms) CTL 1020.05 ± 271.74 CTL 970.99 ± 271.74 CTL 987.15 ± 224.54 0.311 0.050 0.857
MS 1249.00 ± 444.35 MS 1235.45 ± 380.69 MS 1201.96 ± 406.34
COX (%) CTL 100.79 ± 1.41 CTL 102.61 ± 1.56⇤ CTL 103.3 ± 2.09⇤ < 0.001 0.969 0.524
MS 100.36 ± 1.10 MS 103.10 ± 2.89⇤ MS 102.54 ± 1.27⇤
Values are mean ± SD. ⇤p < 0.05 vs. MT test of the same group.
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to the baseline. This MT-induced raise in COX was probably
the consequence of the increased brain activity due to the
mental task, which enhanced brain metabolism and led to COX
elevation (Willie et al., 2014). All COX levels were similar among
conditions with an exception: during the PEMI + MT test of
the CTL group, COX was significantly more elevated than the
baseline. This could demonstrate that adding a mental task to
the PEMI-induced metaboreflex activation increased COX in
normal individuals, but not in individuals su ering from MS,
who were not able to increase COX to the same extent of
CTL participants.
We examined the e ects of experimental sessions on
response times and we used these data to infer information
about the brain mechanisms involved while performing a
mental task during an exercise. We cannot provide any
ultimate explanation for the lacking increase of COX in
MS group when a mental task was superimposed to PEMI:
individuals could have an elevated SNS drive which impaired
the capacity to enhance COX or an impaired cerebral vascular
reactivity or a reduced capacity to maintain COX at a proper
level. Whatever the cause results suggest that individuals
su ering from MS have impaired executive control and
are unable to properly increase COX when a mental task
activity was superimposed the metaboreflex obtained by means
of PEMI maneuver. This phenomenon could explain why
individuals su ering from MS do not meet physical activity
recommendation, since executive functions are necessary for
behavior change and can a ect an individual’s capability to
successfully adopt andmaintain physical activity behavior change
(Olson et al., 2017).
Limitations of the Study
One possible limitation of this study is the response times
of BST assumed as proxies to assess executive functions.
Attention and processing speed are typically categorized as
a general cognitive function; however, they are more related
to executive function domain and to a successful behavioral
change (Olson et al., 2017). The BST is an attentional test,
where color and shape are varied within trials. The task is
similar to other traditional interference tasks (e.g., the Simon
interference task, the color-word Stroop test, and Eriksen’s
flanker task), but not prompts verbal reactions. The task
was already used to assess the ability to suppress irrelevant
information in non-linguistic settings, but more studies are
required to validate this task with adults su ering from MS.
Another possible limitation of the present investigation is that
SNS activity was not directly assessed. This kind of measure
are somewhat invasive and not applicable in experimental
settings such as the present one, with ongoing psychological
stress. A further potential limit of this study is related to the
use of NIRS, compared to other brain imaging techniques,
such as transcranial Doppler (TCD) or functional magnetic
resonance imaging (FMRI). Several studies have confirmed the
sensitivity of NIRS to measure subtle changes in COX during
arithmetic or neuropsychological tasks involving the frontal
lobe such as Stroop test (Ferreri et al., 2014). However, NIRS
su ers of low spatial resolution which makes di cult to detect
changes in areas located distant from the monitored site. On
the other hand, NIRS o ers some advantages as portability,
good motion tolerance, non-invasiveness, and low maintenance
costs. A further limitation of this study is the small size of
the sample of individuals su ering from MS, that asks for
studies replications. Finally, we cannot exclude that asking
participants to refrain from ca einated beverages, alcohol, and
heavy exercise for 12 h before the experimental phase, may
have a ected their routine, and therefore every participant’s
average performance.
CONCLUSION
In conclusion, the results of the present investigation provide
evidence that individuals su ering from MS had worse
cognitive performance, compared to control group, in an
attentional interference task, which involves executive functions.
Individuals with MS were able to enhance COX during
handgrip and during the metaboreflex activation; however,
they could not further enhance COX when a mental task
was superimposed to the metaboreflex. This conclusion could
be intriguing as it may provide a potential psycho–physio–
pathological basis of the scarce predisposition to exercise
often reported in people with MS, since metaboreflex and
cognitive performance are both operating during exercise
(Wasmund et al., 2002) and executive functions are necessary
to initiate and maintain physical activity behavior change
(Olson et al., 2017).
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